news

Sytheon Patents Isosorbide Esters for Skin Diseases, Enters Dermatological Market

Sytheon inventors have discovered certain esters of isosorbide can modify and regulate the expression of genes, genetic networks, and cellular pathways in the skin. The company has patented this invention for the dermatology market.

Assigned to Sytheon, U.S. Patent 10,597,402 discloses, “compositions and methods for restoring epidermal integrity and function and treating dermatol­ogical diseases.” According to the company, these esters can be used to improve and/or address defects or imbalances in keratinocyte differen­tiation.

They also can repair skin barrier building and defend its functioning and integrity, improving overall stratum corneum development, structure, and architecture. Furthermore, the esters are reportedly effective for combating, mitigating, and/or preventing the manifestation of diseased conditions, defects, or imbalances in the skin.

Securing this patent, Sytheon stakes claim through its sister company, Symbionyx Phamaceu­ticals Inc., in the dermatol­ogical market to treat diseases caused by autoimmune imbalances.

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Sytheon’s CEO to Speak at NYSCC Acne Care Symposium

Ratan K. Chaudhuri, Ph.D., President and CEO at Sytheon, will discuss key strategic targets for mitigating acne-affected skin. Sytheon, a...

by Drew FrantzenMay 19, 2023
Read More
Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic…

Sytheon is excited to announce a publication on Synergistic Anti-Inflammatory Effects of Isosorbide Fatty Acid Diesters in Cytokine-Induced Tissue Culture...

by hostingagencyusDecember 6, 2022
Read More
Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10…

Founder and CEO Dr. Ratan Chaudhuri has been named as a top 10 inspiring business leader by Inc. magazine to...

by hostingagencyusOctober 6, 2022
Read More
Sytenol® A is Accepted for Use in the Chinese Market

Sytenol® A is Accepted for Use in the Chinese Market

We are pleased to announce that Sytenol® A (Bakuchiol) has been successfully notified as a medium-low risk new cosmetic ingredient...

by hostingagencyusAugust 31, 2022
Read More
Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon Announces Relocation and Expansion of New Corporate Headquarters

Sytheon relocates its headquarters to 10 Waterview Blvd, Parsippany, NJ. The move to a new state-of-the-art facility stems from Sytheon’s...

by hostingagencyusAugust 1, 2022
Read More
Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach…

Bakuchiol – A natural alternative to Retinol shows holistic treatment approach for facial aging based on its multidirectional activity Beiersdorf...

by hostingagencyusJune 3, 2022
Read More